Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo

被引:29
|
作者
Lotz, Christopher [1 ]
Lazariotto, Maria [2 ]
Redel, Andreas
Smul, Thorsten M.
Stumpner, Jan
Blomeyer, Christoph
Tischer-Zeitz, Tobias
Schmidt, Johannes
Pociej, Joanna
Roewer, Norbert
Kehl, Franz [3 ]
Lange, Markus
机构
[1] Univ Wurzburg, Klin & Poliklin Anasthesiol, Zentrum Operat Med, Dept Anesthesiol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Cardiac Thorac & Thorac Vasc Surg, D-97080 Wurzburg, Germany
[3] Staedt Klinikum Karlsruhe, Dept Anesthesiol, Karlsruhe, Germany
关键词
myocardial ischemia/reperfusion-injury; nitric oxide; cardioprotection; NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; PPAR-ALPHA; REPERFUSION INJURY; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); UP-REGULATION; RABBIT HEART; RAT-HEART; PROTECTION; LIGANDS;
D O I
10.1258/ebm.2010.010210
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Remote ischemic preconditioning (remote IPC) elicits a protective cardiac phenotype against myocardial ischemic injury. The remote stimulus has been hypothesized to act on major signaling pathways; however, its molecular targets remain largely undefined. We hypothesized that remote IPC exerts its effects by activating the peroxisome-proliferator-activated receptors (PPARs) alpha and gamma, which have been previously implicated in cardioprotective signaling. Male New Zealand white rabbits (n = 78) were subjected to a 30-min coronary artery occlusion followed by three hours of reperlusion. Three cycles of remote IPC consisting of 10-min renal ischemia/reperfusion were performed. The animals either received the PPAR alpha-antagonist GW6471 or the PPAR gamma-antagonist GW9662 alone or combined with remote IPC. Infarct size was determined gravimetrically. Tissue levels of 15d-prostaglandin J(2) (15d-PGJ(2)), as well as the PPAR DNA binding were measured using specific assays. Reverse transcriptase polymerase chain reaction was used to analyze changes in endothelial nitric oxide synthase or inducible nitric oxide synthase (iNOS) mRNA expression in relative quantity (RQ). Data are mean +/- SD. As a result, remote IPC significantly reduced the myocardial infarct size (42.2 +/- 4.9%* versus 61 +/- 1.9%), accompanied by an increased PPAR DNA-binding (189.6 +/- 19.8RLU* versus 44.4 +/- 9RLU), increased iNOS expression (3.5 +/- 1RQ* versus 1RQ), as well as 15d-PGJ(2) levels (179.7 +/- 7.9 pg/mL* versus 127.9 +/- 7.6 pg/mL). The protective response elicited by remote IPC, as well as the accompanying molecular changes were abolished by inhibiting PPAR alpha (56.8 +/- 4.7%; 61.1 +/- 14.2RLU; and 1.91 +/- 0.96RQ, respectively) or PPAR gamma (57.4 +/- 3.3%; 52.7 +/- 16.9RLU; and 1.54 +/- 0.25RQ, respectively). (*Significantly different from control P < 0.05). In conclusion, the obtained results indicate that both PPAR alpha and PPAR gamma play an essential role in remote IPC against myocardial infarction, impinging on the transcriptional control of iNOS expression.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 50 条
  • [1] Activation of Peroxisome-Proliferator-activated receptors alpha and gamma mediates remote ischemic preconditioning against myocardial infarction
    Lotz, Christopher
    Redel, Andreas
    Stumpner, Jan
    Thorsten, Smul
    Tischer-Zeitz, Tobias
    Schmidt, Johannes
    Wunder, Christian
    Lange, Markus
    Roewer, Norbert
    Kehl, Franz
    FASEB JOURNAL, 2009, 23
  • [3] Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning
    Lotz, Christopher
    Lange, Markus
    Redel, Andreas
    Stumpner, Jan
    Schmidt, Johannes
    Tischer-Zeitz, Tobias
    Roewer, Norbert
    Kehl, Franz
    EXPERIMENTAL PHYSIOLOGY, 2011, 96 (03) : 317 - 324
  • [4] Peroxisome-proliferator-activated receptors and cancers: Complex stories
    Michalik, L
    Desvergne, B
    Wahli, W
    NATURE REVIEWS CANCER, 2004, 4 (01) : 61 - 70
  • [5] Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain
    Glatz, Torben
    Stoeck, Ivonne
    Nguyen-Ngoc, Miriam
    Gohlke, Peter
    Herdegen, Thomas
    Culman, Juraj
    Zhao, Yi
    JOURNAL OF HYPERTENSION, 2010, 28 (07) : 1488 - 1497
  • [6] Peroxisome-proliferator-activated receptors and cancers: complex stories
    Liliane Michalik
    Béatrice Desvergne
    Walter Wahli
    Nature Reviews Cancer, 2004, 4 : 61 - 70
  • [7] Peroxisome-proliferator-activated receptors: pleiotrophic transcriptional modulators of cardiovascular disease
    van Bilsen, M
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (05) : 765 - 766
  • [8] Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system
    Kim, Teayoun
    Yang, Qinglin
    WORLD JOURNAL OF CARDIOLOGY, 2013, 5 (06): : 164 - 174
  • [9] Peroxisome-proliferator-activated receptor (PPAR)-γ activation stimulates keratinocyte differentiation
    Mao-Qiang, M
    Fowler, AJ
    Schmuth, M
    Lau, P
    Chang, S
    Brown, BE
    Moser, AH
    Michalik, L
    Desvergne, B
    Wahli, W
    Li, M
    Metzger, D
    Chambon, PH
    Elias, PM
    Feingold, KR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02) : 305 - 312
  • [10] Lipid metabolism: peroxisome-proliferator-activated receptors and the regulation of genes of lipid metabolism
    Poisson, JP
    Narce, M
    CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (05) : 583 - 584